UNH Stock Ownership Activity

UNITEDHEALTH GROUP INC 13F holders

19 value investing gurus have made changes to the UNITEDHEALTH GROUP INC (UNH) position according to the gurus' latest SEC quarterly report(s). UNH has been bought (as a new position) by 2, completely sold out by 2 guru(s), the number of UNH shares has been increased by 3, decreased by 12 super investor(s).

Which gurus or hedge funds are buying UNH now?

According to the latest SEC filing(s) UNITEDHEALTH GROUP INC (UNH) has been bought by 5 gurus: Parnassus Investments - Parnassus Endeavor Fund (new buy), Andrew R. Adams - Mairs & Power Growth Fund (added shares +6.97%), Nathaniel Simons - Meritage Group (new buy), Chase Coleman III - Tiger Global Management (added shares +0.76%) and Paul Lountzis - Lountzis Asset Management (added shares +0.04%).

To see more about who is investing in UNITEDHEALTH GROUP INC (UNH), please go to the UNH ownership page.

2023 Q1 (12 results)
Ole Andreas Halvorsen
+65.65%
+832,288
+1.85%
4.68%
Robert Olstein
+41.94%
+3,250
+0.24%
0.81%
David Rolfe
+24.09%
+14,606
+1.17%
6.03%
Paul Lountzis
+7.03%
+819
+0.23%
3.49%
David M. Polen
-0.48%
-13,041
-0.02%
3.38%
Eric H. Schoenstein
-3.38%
-47,090
-0.17%
4.99%
Ravenel Boykin Curry IV
-8.26%
-180,603
-0.39%
4.32%
Glenn Greenberg
-8.29%
-100
-0.00%
0.02%
Stephen Mandel
-16.21%
-172,433
-0.75%
3.90%
Daniel Loeb
-50.00%
-335,000
-2.59%
0.00%
John Armitage
-91.60%
-974,662
-4.97%
0.00%
Francois Rochon
-100.00%
-1,733
-0.06%
0.00%
Current price: $500.13 5.89% AVG reported price*: $472.30
2022 Q4 (15 results)
Francois Rochon
buy
+1,733
+0.06%
0.00%
Ole Andreas Halvorsen
+263.71%
+919,153
+2.45%
3.38%
Eric H. Schoenstein
+15.38%
+185,736
+0.77%
5.78%
Stephen Mandel
+13.21%
+124,144
+0.63%
5.38%
Paul Lountzis
+0.13%
+15
+0.00%
3.33%
Ronald Muhlenkamp
+0.08%
+19
+0.00%
5.56%
David Rolfe
-0.40%
-245
-0.02%
5.90%
Andrew R. Adams
-1.56%
-8,000
-0.10%
6.20%
David M. Polen
-4.35%
-123,918
-0.19%
4.22%
V. D. Dodge, E. M. Cox
-6.15%
-148,300
-0.09%
1.39%
John Armitage
-7.44%
-85,473
-0.39%
4.85%
Robert Olstein
-10.92%
-950
-0.08%
0.64%
Ruane, Cunniff & Goldfarb
-17.06%
-79,350
-1.45%
7.03%
Ravenel Boykin Curry IV
-24.94%
-726,183
-1.83%
5.49%
Glenn Greenberg
-51.09%
-1,260
-0.02%
0.02%
Current price: $500.13 4.96% AVG reported price*: $526.25
2022 Q3 (13 results)
Ole Andreas Halvorsen
buy
+348,550
+0.82%
0.82%
Daniel Loeb
+17.54%
+100,000
+0.92%
6.14%
Stephen Mandel
+17.39%
+139,144
+0.66%
4.47%
Eric H. Schoenstein
+8.41%
+93,674
+0.41%
5.31%
Ravenel Boykin Curry IV
+1.45%
+41,703
+0.10%
6.70%
Ronald Muhlenkamp
+0.86%
+212
+0.05%
5.58%
David M. Polen
-2.30%
-67,080
-0.09%
4.03%
Paul Lountzis
-2.33%
-278
-0.10%
3.99%
David Rolfe
-2.59%
-1,619
-0.15%
5.78%
V. D. Dodge, E. M. Cox
-2.97%
-73,900
-0.05%
1.57%
Andrew R. Adams
-4.99%
-27,000
-0.32%
6.14%
Robert Olstein
-13.00%
-1,300
-0.11%
0.74%
John Armitage
-23.23%
-347,821
-1.36%
4.51%
Current price: $500.13 0.97% AVG reported price*: $505.04
40 of 452

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.